Healthcare advisory Putnam operates as a health and life sciences advisory partner through Inizio Ignite, offering strategy consulting that bridges science and commercial decision-making. Sales teams can position to clients needing integrated R&D to go-to-market strategies, and value, pricing and access insights across pharma pipelines.

Data and AI leverage The firm highlights data and AI strategy as a core offering, suggesting opportunities to sell analytics, evidence generation, and data-driven value assessments to pharma and BioPharma brands seeking evidence-backed commercialization and pricing strategies.

Portfolio depth With an ecosystem spanning Putnam, Vynamic, STEM and other units under Inizio Ignite, there is cross-sell potential to existing clients for branding, medical affairs, access & pricing, and R&D advisory services, enabling bundled solutions.

Growth and market trends The company emphasizes support from early development to loss of exclusivity, presenting opportunities to engage clients across life-cycle stages with strategic planning, market access, and portfolio optimization aligned to market trends and regulatory shifts.

Talent and tech stack A mid-sized advisory with diverse tech tools (Adobe, Qlik, HubSpot, Splunk, etc.) indicates readiness to scale client delivery, suggesting upsell opportunities around technology-enabled insights, digital marketing, and efficiency enhancements for client programs.